Morgan Stanley Reiterates Equal-Weight on Zimmer Biomet Holdings, Maintains $140 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong has reiterated an Equal-Weight rating on Zimmer Biomet Holdings (NYSE:ZBH) and maintained a $140 price target.
August 04, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has reiterated an Equal-Weight rating on Zimmer Biomet Holdings and maintained a $140 price target.
The news is directly about Zimmer Biomet Holdings. Morgan Stanley's reiteration of an Equal-Weight rating and maintenance of a $140 price target suggests that they believe the stock is fairly valued at its current price. This could have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100